Publications by authors named "Mikkel Oestergaard"

Claim this Profile
T
T-cell immunoglobulin and mucin domain 3 is upregulated in rheumatoid arthritis, but insufficient in controlling inflammation.
Caecilie Skejoe, Aida S Hansen, Kristian Stengaard-Pedersen, Peter Junker, Kim Hoerslev-Pedersen, Mikkel Oestergaard

Am J Clin Exp Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction and characterization of diffuse large B-cell lymphoma cell-of-origin subtypes using targeted sequencing.
Sally E Trabucco, Ethan S Sokol, Sophia L Maund, Jay A Moore, Garrett M Frampton, Mikkel Z Oestergaard

Future Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma.
Jonathan C Strefford, Malgorzata Nowicka, Chantal E Hargreaves, Cathy Burton, Andrew Davies, Mikkel Z Oestergaard

Blood Adv· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment.
Malgorzata Nowicka, Laura K Hilton, Margaret Ashton-Key, Chantal E Hargreaves, Chern Lee, Mikkel Z Oestergaard

Blood Adv· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma.
Christopher R Bolen, Federico Mattiello, Michael Herold, Wolfgang Hiddemann, Sarah Huet, Mikkel Z Oestergaard

Blood· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis.
Elizabeth Punnoose, Franklin V Peale, Edith Szafer-Glusman, Guiyuan Lei, Richard Bourgon, Mikkel Z Oestergaard

Clin Lymphoma Myeloma Leuk· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effect of prospective biomarker testing on progression-free survival in diffuse large B-cell lymphoma.
Edith Szafer-Glusman, Juan Liu, Arijit Sinha, Franklin V Peale, Jill Ray, Mikkel Z Oestergaard

Leuk Lymphoma· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA.
Lale Kostakoglu, Maurizio Martelli, Laurie H Sehn, David Belada, Angelo-Michele Carella, Mikkel Z Oestergaard

Blood Adv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study.
Christopher R Bolen, Magdalena Klanova, Marek Trneny, Laurie H Sehn, Jie He, Mikkel Z Oestergaard

Haematologica· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy.
Magdalena Klanova, Mikkel Z Oestergaard, Marek Trněný, Wolfgang Hiddemann, Robert Marcus

Clin Cancer Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL.
Magdalena Klanova, Laurie H Sehn, Isabelle Bence-Bruckler, Federica Cavallo, Jie Jin, Mikkel Z Oestergaard

Blood· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 and tumor-associated macrophages in de novo DLBCL.
Ronald McCord, Christopher R Bolen, Hartmut Koeppen, Edward E Kadel, Mikkel Z Oestergaard

Blood Adv· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma.
Umberto Vitolo, Marek Trněný, David Belada, John M Burke, Angelo Michele Carella, Mikkel Z Oestergaard

J Clin Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE).
Christian Kurzeder, Isabel Bover, Frederik Marmé, Joern Rau, Patricia Pautier, Mikkel Z Oestergaard

J Clin Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Born too soon: the global epidemiology of 15 million preterm births.
Hannah Blencowe, Simon Cousens, Doris Chou, Mikkel Oestergaard, Lale Say

Reprod Health· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Creating policy frameworks for public health genomics to benefit developing countries.
Tikki Pang, Mikkel Oestergaard

Per Med· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
South African child deaths 1990-2011: have HIV services reversed the trend enough to meet Millennium Development Goal 4?
Kate J Kerber, Joy E Lawn, Leigh F Johnson, Mary Mahy, Rob E Dorrington, Mikkel Z Oestergaard

AIDS· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Millennium Development Goals national targets are moving targets and the results will not be known until well after the deadline of 2015.
Mikkel Z Oestergaard, Leontine Alkema, Joy E Lawn

Int J Epidemiol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Child mortality estimation: accelerated progress in reducing global child mortality, 1990-2010.
Kenneth Hill, Danzhen You, Mie Inoue, Mikkel Z Oestergaard,

PLoS Med· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newborn survival: a multi-country analysis of a decade of change.
Joy E Lawn, Mary V Kinney, Robert E Black, Catherine Pitt, Simon Cousens, Mikkel Z Oestergaard

Health Policy Plan· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Method for Deriving Global Estimates of Maternal Mortality.
John R Wilmoth, Nobuko Mizoguchi, Mikkel Z Oestergaard, Lale Say, Colin D Mathers

Stat Politics Policy· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications.
Hannah Blencowe, Simon Cousens, Mikkel Z Oestergaard, Doris Chou, Ann-Beth Moller

Lancet· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neonatal mortality levels for 193 countries in 2009 with trends since 1990: a systematic analysis of progress, projections, and priorities.
Mikkel Zahle Oestergaard, Mie Inoue, Sachiyo Yoshida, Wahyu Retno Mahanani, Fiona M Gore

PLoS Med· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer genetics of epigenetic genes.
Ahmad Miremadi, Mikkel Z Oestergaard, Paul D P Pharoah, Carlos Caldas

Hum Mol Genet· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis